The hidden regulators: Non‐coding RNAs in KMT2A ‐rearranged acute lymphoblastic leukemia
International Journal of Cancer · 2026
DOI: 10.1002/ijc.70283 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Cancer, 2026. Verfasst von Maria Augusta Poersch und 5 weiteren Autor:innen. Beteiligte Einrichtung: Genetics Post-Graduation Program, Genetics Department, Federal University of Parana, Curitiba, Parana, Brazil. Hauptthemen laut MEDLINE: Myeloid-Lymphoid Leukemia Protein, Histone-Lysine N-Methyltransferase, Precursor Cell Lymphoblastic Leukemia-Lymphoma, RNA, Untranslated. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
Acute lymphoblastic leukemia (ALL) driven by KMT2A rearrangements ( KMT2A ‐r) is an aggressive hematologic malignancy with poor prognosis and a high incidence in infants. While KMT2A fusion proteins drive leukemogenesis through transcriptional dysregulation, recent discoveries have highlighted the pivotal role of non‐coding RNAs (ncRNAs) in shaping the molecular and epigenetic landscape of this disease. These key regulators of gene expression influence chromatin dynamics, transcriptional activation, and post‐transcriptional control. Circular RNAs (circRNAs) contribute to genome instability and facilitate chromosomal translocations, while some fusion‐derived circRNAs (f‐circRNAs) sustain oncogenic signaling and promote chemoresistance. Long non‐coding RNAs (lncRNAs) orchestrate transcriptional programs that maintain leukemic stem cell properties and reinforce aberrant self‐renewal pathways. MicroRNAs (miRNAs) modulate critical oncogenic networks by regulating KMT2A fusion transcripts and downstream effectors, thereby impacting drug resistance, apoptosis, and proliferation. Meanwhile, enhancer RNAs (eRNAs) fine‐tune transcriptional activity and epigenetic regulation, influencing KMT2A target gene expression and chromatin accessibility. Collectively, these ncRNAs integrate into the complex regulatory circuits of KMT2A ‐r ALL, revealing their potential as biomarkers for disease classification, risk stratification, and treatment response prediction. Understanding their interplay with KMT2A fusion proteins not only provides new insights into leukemogenesis but also highlights promising opportunities for therapeutic intervention and precision medicine in this high‐risk leukemia subtype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genetics Post-Graduation Program, Genetics Department, Federal University of Parana, Curitiba, Parana, Brazil.
ORCID-Profile: Maria Augusta Poersch, Jaqueline Carvalho de Oliveira
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Poersch, M. A., Rodrigues, A. C., Stricker, P. E. F., Azevedo, A. L. K., Bruschi, D. P., & de Oliveira, J. C. (2026). The hidden regulators: Non‐coding RNAs in KMT2A ‐rearranged acute lymphoblastic leukemia. International Journal of Cancer. https://doi.org/10.1002/ijc.70283
Vancouver
Poersch MA, Rodrigues AC, Stricker PEF, Azevedo ALK, Bruschi DP, de Oliveira JC. The hidden regulators: Non‐coding RNAs in KMT2A ‐rearranged acute lymphoblastic leukemia. International Journal of Cancer. 2026. doi:10.1002/ijc.70283
BibTeX
@article{Poersch2026,
author = {Poersch, Maria Augusta and Rodrigues, Ana Carolina and Stricker, Priscila Elias Ferreira and Azevedo, Alexandre Luiz Korte and Bruschi, Daniel Pacheco and de Oliveira, Jaqueline Carvalho},
title = {The hidden regulators: Non‐coding RNAs in KMT2A ‐rearranged acute lymphoblastic leukemia},
journal = {International Journal of Cancer},
year = {2026},
doi = {10.1002/ijc.70283}
}
EUVIMED